UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of April, 2015

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F

Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes

ISRAEL CHEMICALS LTD.

1.	Immediate Report Regarding a Dividend Distribution – Supplemental Report (April 13, 2015)

Item 1

Immediate Report Regarding a Dividend Distribution – Supplemental Report

Further to the Company's report dated March 22, 2015 (reference number 2015-02-056575) regarding a dividend distribution out of the revenues of the fourth quarter of 2014 in the amount of $59,500,000, the Company wishes to report that the dividend amount per share in US dollars is $0.04680, and the dividend amount per share for shareholders who will receive the payment in Shekels is ILS 0.1878454 based on the representative exchange rate published on April 13, 2015.

The dividend will be paid only to registered shareholders entitled to US$2 or above. The payment day is April 29, 2015.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 13, 2015

Israel Chemicals Ltd.

/s/ Kobi Altman

Kobi Altman

Executive Vice President and Chief Financial Officer